Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus
- 1 October 2018
- journal article
- review article
- Published by Elsevier BV in JACC: Heart Failure
- Vol. 6 (10), 813-822
- https://doi.org/10.1016/j.jchf.2018.05.020
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
- European Commission
- Janssen Pharmaceuticals
- AstraZeneca
- HeartWare
- GlaxoSmithKline
- Bayer Fund
- Merck
- Luitpold Pharmaceuticals
- Amgen
- ResMed
- Gilead Sciences
- National Institutes of Health (R01AG045551-01A1, U10HL110312)
- Boehringer Ingelheim
- Novartis
This publication has 39 references indexed in Scilit:
- Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart FailureCirculation: Heart Failure, 2013
- Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialEuropean Heart Journal, 2010
- Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research databaseBMJ, 2009
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trialDiabetes Care, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Metformin in Heart FailureDiabetes Care, 2007
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974